Steven W. Paugh - Concepedia

Author

Steven W. Paugh

St. Jude Children's Research Hospital ORCID

Also Known As

S W Paugh, Steven Paugh, Steven W Paugh, Steven W. Paugh, Steven William Paugh, Steven W. Paugh

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

St. Jude Children's Research Hospital Virginia Commonwealth University National Institute of Mental Health University of California, San Francisco University of Florida

About

Steven W. Paugh is an author at St. Jude Children's Research Hospital specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.5K
2	Cell Biology	7	7	1.4K
3	Health Sciences	1	1	15
4	Natural Sciences	1	1	54
5	Cellular Physiology	1	1	348

Steven W. Paugh

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia Kathryn G. Roberts, Yongjin Li, Debbie Payne-Turner, New England Journal of Medicine	2014	1.4K
Novel mutations target distinct subgroups of medulloblastoma Giles Robinson, Matthew Parker, Tanya A. Kranenburg, Nature	2012	845
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia Kathryn G. Roberts, Ryan D. Morin, Jinghui Zhang, Cancer Cell Hematological MalignancyCell SignalingMalignant Blood DisorderMixed-phenotype Acute LeukemiaImmunology	2012	699
Apoptosis induces expression of sphingosine kinase 1 to release sphingosine‐1‐phosphate as a “come‐and‐get‐me” signal David Gude, Sergio E. Alvarez, Steven W. Paugh, The FASEB Journal Chemoprevention StrategyApoptosisImmunologyPan-sphingosine KinaseCell Death	2008	348
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2 Steven W. Paugh, Shawn G. Payne, Suzanne E. Barbour, FEBS Letters	2003	305
Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia B Diouf, Kristine R. Crews, Glen Lew, JAMA	2015	271
A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia Steven W. Paugh, Barbara S. Paugh, Mohamed Rahmani, Blood	2008	246
Sphingosine kinase 1 is required for migration, proliferation and survival of MCF‐7 human breast cancer cells Sukumar Sarkar, Michael Maceyka, Nitai C. Hait, FEBS Letters	2005	202
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells Steven W. Paugh, Erik Bonten, Daniel Savic, Nature Genetics Casp1 CleavageSignal TransductionNalp3 Inflammasome UpregulationImmunologyPathology	2015	158
Involvement of Sphingosine Kinase 2 in p53-Independent Induction of p21 by the Chemotherapeutic Drug Doxorubicin Heidi Sankala, Nitai C. Hait, Steven W. Paugh, Cancer Research	2007	156

Page 1